Mylan CEO Claims EpiPens Aren’t As Profitable As Everyone Thinks
(By Alison Kodjak for NPR) The drug company that makes the EpiPen says it isn’t nearly as profitable as many
Read More
Author: Eileen Cook
Breaking Taboo, Swedish Scientist Seeks To Edit DNA Of Healthy Human Embryos
(By Rob Stein for NPR) A scientist in Sweden has started trying to edit the DNA in healthy human embryos,
Read More100 hospitals with great heart programs | 2016
(By Ayla Ellison and Mackenzie Bean for Becker’s Hospital Review ) Becker’s Hospital Review has named the following organizations to the
Read MoreAre You Part of the Silver Tsunami?
Ten thousand seniors turning 65 and becoming Medicare-eligible every day but not one of Silicon Valley companies is taking senior
Read MoreHow Much Has Medicare Spent on the EpiPen Since 2007?
(By Juiette Cubanski, Tricia Neuman, and Anthony Damico for Kaiser Family Foundation) The latest example of high and rising prescription
Read MoreWeight Loss On Your Wrist? Fitness Trackers May Not Help
(Erin Ross for NPR) Fitness trackers remain wildly popular, but do they make us fit? Maybe not, according to a
Read MoreVeterans Courted In California’s Ballot Fight Over Curbing Drug Prices
(By Pauline Bartolone for California Healthline) Once a month at the Veterans of Foreign Wars building in Sacramento, a couple
Read MoreCalifornia governor decries ‘predatory’ pricing as he signs law to make EpiPen available
(By Ed Silverman for STAT) For all intents and purposes, California Governor Jerry Brown held his nose Friday as he
Read MoreCompetition in Medicare Advantage, Part D, and “Extra Help”:
(By Grace-Marie Turner for Galen Institute) Seniors are beginning to get fliers in the mail alerting them to the upcoming
Read MoreSarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
(By Ed Silverman for STAT) The newly approved1 Sarepta Therapeutics drug for Duchenne muscular dystrophy2 will cost about $300,000 a
Read More